Martha Glenn

4.1k total citations
41 papers, 813 citations indexed

About

Martha Glenn is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Martha Glenn has authored 41 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 18 papers in Pathology and Forensic Medicine and 11 papers in Hematology. Recurrent topics in Martha Glenn's work include Chronic Lymphocytic Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (17 papers) and Acute Lymphoblastic Leukemia research (9 papers). Martha Glenn is often cited by papers focused on Chronic Lymphocytic Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (17 papers) and Acute Lymphoblastic Leukemia research (9 papers). Martha Glenn collaborates with scholars based in United States, United Kingdom and China. Martha Glenn's co-authors include Stephen A. Strickland, Joseph Mıkhael, Éric Charpentier, Karl Hsu, Andrew D. Zelenetz, Thomas G. Martin, Thomas G. Martin, André Goy, Andrzej Kaszuba and Harald Gollnick and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Martha Glenn

37 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha Glenn United States 15 334 275 250 220 206 41 813
Craig A. Portell United States 16 409 1.2× 322 1.2× 281 1.1× 117 0.5× 154 0.7× 65 765
Beata Holkova United States 13 297 0.9× 307 1.1× 139 0.6× 155 0.7× 222 1.1× 48 634
Matthew Ku Australia 12 531 1.6× 526 1.9× 262 1.0× 89 0.4× 97 0.5× 47 821
Marolleau Jp France 7 654 2.0× 487 1.8× 290 1.2× 99 0.5× 256 1.2× 11 919
Paolo Fiumara Italy 12 303 0.9× 282 1.0× 140 0.6× 75 0.3× 196 1.0× 28 684
Qin Huang United States 16 245 0.7× 238 0.9× 263 1.1× 398 1.8× 220 1.1× 62 887
Jakob Werner Hansen Denmark 13 414 1.2× 264 1.0× 260 1.0× 218 1.0× 216 1.0× 39 822
Renato Alterini Italy 16 443 1.3× 185 0.7× 99 0.4× 102 0.5× 86 0.4× 42 840
Unn‐Merete Fagerli Norway 13 201 0.6× 278 1.0× 138 0.6× 261 1.2× 286 1.4× 33 744
Gail Ryan Australia 13 378 1.1× 328 1.2× 176 0.7× 77 0.3× 267 1.3× 20 973

Countries citing papers authored by Martha Glenn

Since Specialization
Citations

This map shows the geographic impact of Martha Glenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Glenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Glenn more than expected).

Fields of papers citing papers by Martha Glenn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Glenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Glenn. The network helps show where Martha Glenn may publish in the future.

Co-authorship network of co-authors of Martha Glenn

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Glenn. A scholar is included among the top collaborators of Martha Glenn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Glenn. Martha Glenn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Randa, Yuji Chen, Shane Lloyd, et al.. (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer. 128(19). 3564–3572. 6 indexed citations
2.
Feusier, Julie, Brian J. Avery, Justin A. Williams, et al.. (2021). Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk. PubMed. 5. 189–199.
3.
Martin, Thomas G., Stephen A. Strickland, Martha Glenn, et al.. (2019). Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma. Blood Cancer Journal. 9(4). 41–41. 70 indexed citations
4.
Glenn, Martha, Karen Curtin, Brandt Jones, et al.. (2019). Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees. Blood Cancer Journal. 9(3). 25–25. 3 indexed citations
5.
Stephens, Deborah M., Ying Huang, Akwasi Agyeman, et al.. (2019). Selinexor Combined with Ibrutinib Demonstrates Tolerability and Efficacy in Advanced B-Cell Malignancies: A Phase I Study. Blood. 134(Supplement_1). 4310–4310. 4 indexed citations
6.
Wang, Jiawei, Lian Li, Jiyuan Yang, et al.. (2019). Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine. Nanomedicine Nanotechnology Biology and Medicine. 16. 217–225. 21 indexed citations
7.
Meeks, Huong, Yuan Wan, Erica Johnstone, et al.. (2018). Transgenerational effects of chemotherapy: Both male and female children born to women exposed to chemotherapy have fewer children. Cancer Epidemiology. 56. 1–5. 6 indexed citations
8.
Patel, Shiven B., Clinton C. Mason, Martha Glenn, et al.. (2017). Genomic analysis of adult B-ALL identifies potential markers of shorter survival. Leukemia Research. 56. 44–51. 12 indexed citations
9.
Hesseling, Peter, et al.. (2017). Kaposi’s sarcoma: Good outcome with doxorubicin, bleomycin and vincristine sulphate (ABV) chemotherapy and highly active antiretroviral therapy. South African Medical Journal. 107(11). 952–952. 1 indexed citations
10.
Ma, Jun, et al.. (2013). Testing Women With Endometrial Cancer for Lynch Syndrome: Should We Test All?. Journal of the Advanced Practitioner in Oncology. 4(5). 322–30. 2 indexed citations
11.
Martin, Thomas G., Stephen A. Strickland, Martha Glenn, et al.. (2013). SAR650984, a CD38 Monoclonal Antibody In Patients With Selected CD38+ Hematological Malignancies- Data From a Dose-Escalation Phase I Study. Blood. 122(21). 284–284. 29 indexed citations
12.
Zelenetz, Andrew D., Ranjana H. Advani, John C. Byrd, et al.. (2011). Non-Hodgkin's Lymphomas. Journal of the National Comprehensive Cancer Network. 9(5). 484–560. 110 indexed citations
13.
Gollnick, Harald, Zoé Kececioglu Draelos, Martha Glenn, et al.. (2009). Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. British Journal of Dermatology. 161(5). 1180–1189. 85 indexed citations
14.
Tward, Jonathan D., Martha Glenn, Michael A. Pulsipher, Phillip Barnette, & David K. Gaffney. (2007). Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma. Leukemia & lymphoma. 48(8). 1482–1495. 6 indexed citations
15.
Agarwal, Archana M., Neeraj Agarwal, Martha Glenn, & Megan S. Lim. (2007). Blastic Transformation of Low-Grade Follicular Lymphoma. Journal of Clinical Oncology. 25(16). 2326–2328. 4 indexed citations
16.
Chen, Zhong, et al.. (2005). A Practical Approach to the Detection of Prognostically Significant Genomic Aberrations in Multiple Myeloma. Journal of Molecular Diagnostics. 7(5). 560–565. 7 indexed citations
17.
Wendland, Merideth M, Alexander Tsodikov, Martha Glenn, & David K. Gaffney. (2004). Time interval to the development of breast carcinoma after treatment for Hodgkin disease. Cancer. 101(6). 1275–1282. 9 indexed citations
18.
19.
20.
Gilles, Frédéric, Martha Glenn, André Goy, Yvonne Remache, & Andrew D. Zelenetz. (2000). A novel gene STORP (STOmatin‐Related Protein) is localized 2 kb upstream of the promyelocytic gene on chromosome 15q22. European Journal Of Haematology. 64(2). 104–113. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig A. Portell Breakdown of academic impact, for papers by Beata Holkova Breakdown of academic impact, for papers by Matthew Ku Breakdown of academic impact, for papers by Marolleau Jp Breakdown of academic impact, for papers by Paolo Fiumara Breakdown of academic impact, for papers by Qin Huang Breakdown of academic impact, for papers by Jakob Werner Hansen Breakdown of academic impact, for papers by Renato Alterini Breakdown of academic impact, for papers by Unn‐Merete Fagerli Breakdown of academic impact, for papers by Gail Ryan
Rankless by CCL
2026